Consolidated Portfolio Review Corp Black Rock Health Sciences Trust Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 38,879 shares of BME stock, worth $1.38 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
38,879
Previous 28,867
34.68%
Holding current value
$1.38 Million
Previous $1.12 Billion
27.08%
% of portfolio
0.2%
Previous 0.18%
Shares
9 transactions
Others Institutions Holding BME
# of Institutions
75Shares Held
3.09MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY369KShares$13.1 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA343KShares$12.2 Million0.0% of portfolio
-
Nova R Wealth, Inc.281KShares$9.98 Million5.08% of portfolio
-
Shaker Financial Services, LLC225KShares$7.97 Million3.05% of portfolio
-
Invesco Ltd. Atlanta, GA201KShares$7.12 Million0.0% of portfolio
About BlackRock Health Sciences Trust
- Ticker BME
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...